Render Target: STATIC
Render Timestamp:
4/1/2025, 6:40:06 AM EDT
4/1/2025, 10:40:06 AM UTC
Commit: 461ca8d8fe5b1efd4c01fc87e5b5eb592e2d154a
XML generation date: 2025-03-07 13:17:08.776
Product last modified at: 2025-02-20T18:00:10.591Z
Cell Signaling Technology Logo
View Featured Offers >>
1% for the planet logo
PDP - Template Name: Antibody Sampler Kit
PDP - Template ID: *******4a3ef3a
  1. Products /
  2. Primary Antibodies /
  3. Electron Transport Chain (Complex I, III, IV) Antibody Sampler Kit

Electron Transport Chain (Complex I, III, IV) Antibody Sampler Kit #42642

    Product Information

    Kit Usage Information

    Protocols

    Product Description

    The Electron Transport Chain (Complex I, III, IV) Antibody Sampler Kit provides an economical means of detecting select components involved in the electron transport chain (ETC) (Complex I, III, IV). The kit includes enough antibodies to perform two western blot experiments with each primary antibody.

    Background

    Mitochondrial acyl carrier protein (ACP) is an essential component in fatty acid biosynthesis in mitochondria. It is also known as NADH-ubiquinone oxidoreductase subunit AB1 (NDUFAB1), a Complex I subunit in the electron transport chain (ETC). NDUFAB1 regulates energy and reactive oxygen species (ROS) metabolism in mitochondria by coordinating the assembly of ETC Complexes I, II, and III, and supercomplexes (1). NDUFS1 (NADH dehydrogenase Fe-S protein 1) is a nuclear-encoded structural subunit of NADH: ubiquinone oxidoreductase (Complex I) in the mitochondrial ETC (2). Mutations in NDUFS1 and other Complex I subunits leading to mitochondrial dysfunction are associated with a number of neurological disorders (3-6). Ubiquinol-cytochrome c reductase iron-sulfur subunit (UQCRFS1), also known as Rieske iron-sulfur protein (RISP), is a component of Complex III in the mitochondrial ETC. UQCRFS1/RISP and two other subunits, cytochrome b (MT-CYB) and cytochrome c1 (CYC1), are essential for the catalytic activity of Complex III (7). Cytochrome c is a well conserved electron transport protein and is part of the respiratory chain localized to mitochondrial intermembrane space (8). Upon apoptotic stimulation, cytochrome c released from mitochondria associates with procaspase-9 (47 kDa)/Apaf-1. This complex processes caspase-9 from inactive proenzyme to its active form (9). This event further triggers caspase-3 activation and eventually leads to apoptosis (10). The mitochondrial ETC comprises multiple protein complexes, including cytochrome c oxidase. Cytochrome c oxidase catalyzes the reduction of oxygen to water. This process is coupled with pumping protons from the mitochondrial matrix into mitochondrial intermembrane space, contributing to the proton gradient used for ATP synthesis (11). Cytochrome c oxidase consists of 3 mitochondrial DNA-encoded subunits (COX1/MT-CO1, COX2/MT-CO2, and COX3/MT-CO3) and multiple nuclear DNA-encoded subunits (12). Research studies show that the mRNAs of the mitochondrially encoded oxidative phosphorylation subunits, including COX1/MT-CO1, decline significantly during aging (13). Cytochrome c oxidase (COX, also known as Complex IV) is a hetero-oligomeric enzyme consisting of 13 subunits localized to the inner mitochondrial membrane (14-16). It is the terminal enzyme complex in the respiratory chain, catalyzing the reduction of molecular oxygen to water coupled to the translocation of protons across the mitochondrial inner membrane to drive ATP synthesis. The 3 largest subunits forming the catalytic core are encoded by mitochondrial DNA, while the other smaller subunits, including COX IV, are nuclear-encoded. Research studies have shown that deficiency in COX activity correlates with a number of human diseases (17). COX10 is an assembly factor for cytochrome c oxidase in the mitochondrial ETC (18,19). Studies show that, when the gene encoding the β2-adrenergic receptor (Adrb2) is deleted, increased oxidative phosphorylation in endothelial cells inhibits angiogenesis. Deletion of Cox10 prevents the metabolic switch to oxidative phosphorylation in endothelial cells deleted of Adrb2, causing angiogenesis and cancer progression (19). In addition, COX10 contributes to T cell quiescence exit and is critical for T cell activation (20).
    1. Hou, T. et al. (2019) Cell Res 29, 754-766.
    2. Duncan, A.M. et al. (1992) Cytogenet Cell Genet 60, 212-3.
    3. Petruzzella, V. et al. (2012) Adv Exp Med Biol 942, 371-84.
    4. Pagniez-Mammeri, H. et al. (2012) Mol Genet Metab 105, 163-72.
    5. Kashani, A. et al. (2014) Neurogenetics 15, 161-4.
    6. Zhu, Y. et al. (2015) J Hum Genet 60, 11-6.
    7. Maio, N. et al. (2017) Cell Metab 25, 945-953.e6.
    8. Schägger, H. (2002) Biochim Biophys Acta 1555, 154-9.
    9. Li, P. et al. (1997) Cell 91, 479-89.
    10. Liu, X. et al. (1996) Cell 86, 147-57.
    11. Nolfi-Donegan, D. et al. (2020) Redox Biol 37, 101674.
    12. Zong, S. et al. (2018) Cell Res 28, 1026-1034.
    13. Gomes, A.P. et al. (2013) Cell 155, 1624-38.
    14. Ostermeier, C. et al. (1996) Curr Opin Struct Biol 6, 460-6.
    15. Capaldi, R.A. et al. (1983) Biochim Biophys Acta 726, 135-48.
    16. Kadenbach, B. et al. (2000) Free Radic Biol Med 29, 211-21.
    17. Barrientos, A. et al. (2002) Gene 286, 53-63.
    18. Tarasenko, T.N. et al. (2017) Cell Metab 25, 1254-1268.e7.
    19. Zahalka, A.H. et al. (2017) Science 358, 321-326.
    20. Tan, H. et al. (2017) Immunity 46, 488-503.

    Database Links

    UniProt ID: P28331 , P00395 , P13073 , O14561 , Q12887 , P99999 , P47985


    Entrez-Gene Id: 4719 , 4512 , 1327 , 4706 , 1352 , 54205 , 7386


    Limited Uses

    Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

    Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.